INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 369 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.08 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,033,166 | -22.5% | 64,300 | 0.0% | 0.01% | -22.2% |
| Q2 2023 | $2,622,154 | +18.0% | 64,300 | +7.9% | 0.01% | +12.5% |
| Q1 2023 | $2,221,926 | +36.4% | 59,617 | +27.7% | 0.01% | +33.3% |
| Q4 2022 | $1,628,979 | -33.6% | 46,689 | +6.4% | 0.01% | -40.0% |
| Q3 2022 | $2,455,000 | -0.3% | 43,875 | -7.8% | 0.01% | +11.1% |
| Q2 2022 | $2,463,000 | -15.7% | 47,585 | +18.4% | 0.01% | 0.0% |
| Q1 2022 | $2,920,000 | -38.5% | 40,180 | 0.0% | 0.01% | -35.7% |
| Q4 2021 | $4,751,000 | -5.8% | 40,180 | +6.8% | 0.01% | -12.5% |
| Q3 2021 | $5,045,000 | -23.9% | 37,607 | -8.2% | 0.02% | -27.3% |
| Q2 2021 | $6,633,000 | +141.0% | 40,967 | +19.5% | 0.02% | +120.0% |
| Q1 2021 | $2,752,000 | – | 34,286 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 1,615,321 | $23,697,000 | 41.29% |
| ARK Investment Management | 8,741,432 | $128,237,000 | 3.23% |
| Nikko Asset Management Americas, Inc. | 7,178,520 | $105,309,000 | 1.66% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $1,635,000 | 0.86% |
| Elmwood Wealth Management, Inc. | 64,204 | $942,000 | 0.82% |
| 361 CAPITAL LLC | 94,772 | $1,390,000 | 0.38% |
| Artal Group S.A. | 199,700 | $2,930,000 | 0.11% |
| StoneX Group Inc. | 14,982 | $220,000 | 0.09% |
| Sumitomo Mitsui Trust Holdings, Inc. | 7,178,520 | $105,309,000 | 0.08% |
| PDT Partners, LLC | 85,517 | $1,255,000 | 0.08% |